AbbVie Inks $24M Deal With Calif. Regulators In Humira Case
By Hailey Konnath · August 6, 2020, 8:09 PM EDT
AbbVie Inc. has agreed to shell out $24 million and reform the marketing of its arthritis drug Humira in California to resolve a state Department of Insurance suit accusing the company...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login